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The H-2 system of the IXth linkage group in the mouse determines cell membrane 
components which, in proper donor-recipient combinations, can induce both cellular 
and humoral responses.  The H-2  antigens can therefore be  studied by both trans- 
plantation and serological  methods.  The H-2  system  is complex  serologically  (one 
H-2 chromosome determines more than one antigen) and genetically (crossing-over 
occurs within the system). The H-2 segment of the chromosome is divided into two 
regions, D  and K, by the Ss locus  (14). 1 The Ss locus controls a  serum protein(s) 
which can be recognized by xeno-(Ss)  and allo-(Slp)  antisera (12, 19). The locus is 
separable from the regions controlling the H-2 antigens by recombination (15). 1 The 
Ss protein is not an integral part of the cell membrane and it does not behave like a 
transplantation antigen (20). At least one of its components (Sip)  is subject to hor- 
monal control (13). All this indicates that the Ss locus is genetically and functionally 
distinct from, and apparently unrelated to, the H-2 loci. The presence of an unrelated 
gene(s)  in the middle of  the H-2 segTnent requires that the two regions, H-2D and 
H-2K, be regarded as two distinct genetic entities. They could be either single genes 
or  gene  complexes.  Until recently,  genetic evidence seemed  to  support  the  latter 
possibility; serological analyses of intra-H-2 recombinants seemed  to indicate further 
genetic divisions of the two regions,  D into D, C, V, and E, and K into K and A  (15, 
16). The frequency of crossing-over between H-2D and H-2K was calculated to be of 
the order of 0.5%  (15).  Under normal circumstances, this is too high for intragenic 
crossing-over and thus the most likely explanation  from this finding was that the D and 
K segments of the H-2 complex were each composed  of several genes. 
However, some new data have led to a reinterpretation of the genetic structure of 
the H-2 system and the proposal of a  simplified  model consisting of only two histo- 
compatibility regions (loci) (10). The new interpretation is based on the assumption 
that  there  is  serological  cross-reactivity between  the  antigens determined by  the 
H-2K locus and the antigens determined by the H-2D locus.  The difference between 
the two interpretations can be illustrated by the following example. 
Among  the first  intra-H-2  crossovers  discovered  were  two  called  H-2  h-o°  and 
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11-2 i-o°. Both were derived from F1 hybrids between the same two strains, A  (H-2  a) 
and C57BL  (It-2b).  The 1t-2  n-°°  crossover received the H-2D region from 11-2  b and 
the tt-2K  region from  H-2a;  the 11-2 i'a°  crossover received the H-2D  region from 
H-2  a and the tt-2K region from H-2  b (5). In both cases the crossing-over took place 
between the Ss-Slp  locus and  the H-2D  region  (16).  (Both  crossovers received the 
Ss-Slp locus together with the H-2K region.) When tested with a  specific antiserum 
which defines antigen H-2.3, strain C57BL is negative; strain A and both crossovers 
are positive. Together these data can be interpreted as evidence for separation of an 
H-2C region, controlling antigen//-2.3, from the H-2D  and Ss-Slp regions. It could 
be assumed  that in H-2  h-a°  the crossing-over took place between tt-2D  and H-2C, 
and in H-2 i-a° between H-2C and Ss-Slp, as diagrammed below: 
H-2  '~  11  Sip  a  3[  4.__+ H_2h.o °  11  Slp  '~  3  2 
11-2  b  33  Slp°  I  2 
11-2  a  11  SlpaJi  3  4 
Slp-oi~  2  ~  tl-2 "G°  33  Slp°  3  4  H-2  b  33 
In this way,  three regions controlling histocompafibility antigens could be defined, 
K, C,  and D. However, the two crossovers could also be interpreted in a  somewhat 
less orthodox way. Let us assume that anti-H-2.3 reacts with the H-2D product and 
cross-reacts with the H-2K product of the H-2 '~ chromosome. Then the two crossover 
events could also be interpreted as follows: 
H-2  a  (11  "3")  SlpaJ  E  (3  4)__~  H_2h_a °  (11  "3")  SZp  a  2 
H-2  b  33  Slp°i  2 
H-2 a  (11  "3")  Slpai~  (3  4)  ~ 11-2  -ioo  33  Sip  °  (3  4) 
H-2  b _33 .....  S_Ip°~  2 
In  this case,  there would be no need  to  assign antigen H-2.3  to a  region separate 
from  regions H-2K  and  H-2D. 
Similar interpretations can  also  be  applied to  regions H-2E  and  H-2A.  Region 
tl-2V is required only to code for antigen H-2.22. However, recent evidence seems 
to indicate that this antigen may be identical with antigen H-2.2, and therefore, there 
seems to be no need for a  separate H-2V region. These, plus a number of additional, 
more complex considerations (18), led to the postulation of the new model. By eliminat- 
ing regions A, E,  V,  and C,  the only two regions remaining are K  and D, and  the 
present data can be fitted to this concept in a much more satisfying way. 
Thus,  at the present time, one has a choice between two genetic interpreta- 
tions of the H-2 system: A traditional one with no less than six separate regions 
controlling  transplantation  antigens,  and  an  unorthodox  one  with  only  two 
histocompatibility regions. In this communication we present evidence support- 
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Materials  and  Methods 
H-2 Crossover Strains.--Over  35 intra-H-2 crossovers have been reported in the literature 
(15). Of these, 15 have been subjected to detailed serological analysis and have been shown to 
represent 12 different crossover types. In addition, at least two more H-2 chromosomes are 
thought  (but not proven)  to be derived from other known H-2 chromosomes by intra-H-2 
recombination. This makes a  total of 14 different crossover types, of which 12 were used in 
the present study. They were the following: 
H-2 a  is  a  suspected  crossover  chromosome,  possibly  derived  from  chromosomes H-2 d 
and H-2 k, The crossover origin of H-2 ~ was first suggested after it was shown that H-2d/H-2 k 
hybrids accept H-2 ~ grafts (24). The H-2 ~ chromosome is now available on two inbred back- 
grounds as strains A and B10,A. In the present study, the strain B10.A was used. 
H-2  "z  is a  proven crossover derived from chromosomes H-2 d and H-2 k  (3). 1, 2  It  differs 
from H-2 ~ at the Ss-Slp locus (H-2 ~ is SshSlp o; H_2a~ is Ss tSlp o). The H-2  ~  chromosome is 
available on the A strain background as congenic resistant (CR) 3 line A.AL which was used 
in the present study. 
H-2o  is a  crossover  derived from hybrids between BALB/c  (11-2  d)  and  C57BL  (H-2  ~) 
(5).  Since its discovery it has been maintained as a  separate line, HTG,  mostly by sib-sib 
matings.  A  congenic line B10.H-2~  is being produced by  Dr.  Frank  Lilly,  Department  of 
Genetics, Albert Einstein College of Medicine, New York, but the line was not available at 
the time of this experiment. The line used by us is a  descendant from the original Gorer line. 
H-2  ha chromosome is present in at least three independent crossover lines. All  three lines 
were originally derived from hybrids between A  (H-2 ~)  and C57BL  (H-2  b) strains. The  first 
H-2  h crossover was described by Gofer  (5)  and assigned a  symbol H-2 h- oo  (26). The cross- 
over chromosome is not available on any defined inbred background although the HTH line 
has  been  maintained  mostly  by  sib-sib  matings.  The  other  two  crossover  chromosomes, 
H-2 h-so and H-2 t~-3s~, are available on C57BL/10  background as CR lines  B10.A(1R)  and 
B10.A(2R),  respectively (25,  26).  Serologically there seems to be no difference between the 
products of the three H-2 h chromosomes. Since they all carry the Slp"  allele at the Ss-Slp 
locus, we shall use here, an abbreviated symbol H-2  l'~' for all three of them (a in the super- 
script standing for the Slp '~ allele). Of the three lines, only B10.A(2R)  was employed in the 
experiment described below. 
H-2 t~° was also derived from strains A and C57BL/10  (25,  26). It is now available as CR 
line B10.A(4R).  The chromosome has been originally assigned a  symbol H-2  h-2sg  (26).  In 
this paper, we abbreviate this to H-2 h° since, at the present time, the only known difference 
between 11-2 ~'~  and  H-2  h° is at  the S~-Slp  locus.  (Strain B10.A[4R]  carries allele  Slp°,  see 
reference 20.) 
H-2 i° is the third of the three original Gofer crossovers (5).  It was derived from strains 
A and C57BL. The recombinant chromosome was originally assigned symbol H-2 i and later 
H-2 i-a°  (26).  We abbreviate this symbol to H-2 i° because the chromosome carries the Slp° 
allele at  the Ss-Slp  locus  (20).  The H-2 i° chromosome is now present only in a  line called 
HTI which is derived from the original Gorer crossover and has been maintained mostly by 
sib-sib rantings. No CR line with the H-2 i° chromosome is available at present. 
H-2  ~'  is present in  at  least  two  crossover lines,  B10.A(3R)  with  chromosome  H-2 i-sg 
and B10.A(5R) with chromosome II-2 i-2so  (25,  26). Both lines are on C57BL/10 background. 
Since the H-2 products of these two lines are indistinguishable, and the H-2 i's~ and H-2 i-2s~ 
2 David, C. S., and D. C. Shreflter. 1972.  Studies on recombination within the mouse H-2 
complex.  II.  Serological  analyses  of  four  recombinants,  H-2  ~l,  H-2  °l,  H-2  tl,  and  H-2  tt'. 
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chromosomes differ from H-2 i° apparently only at the Ss-Slp locus, we use the symbol H-2  i" 
(for Sip ~) for both crossover lines. In the present experiment only line B10.A(5R)  was used. 
H-2  '~  is  another  suspected crossover chromosome, possibly derived from  chromosomes 
H-2 e and H-2q. Its crossover origin has been discussed by us previously (9). The chromosome 
is present on two inbred backgrounds: AKR, as a  CR line AKR.M (22), and C57BL/10 as 
B10.AKM (25). We have used only the B10.AKM line. 
H-2 °h was derived from strains DBA/2 (H-2  ~) and C3H  (H-2 k)  (17, 21). It is now avail- 
able on C3H background in CR line C3H.OH. 
H-2  °l was derived from the same two strains as H-2 °h (3). 1' 2 The two chromosomes ap- 
parently differ only at  the Ss-Slp  locus  (H-2 °h is  SshSlp";  H-2 °l  is  Ss 1Slp°).  The  H-2  °Z 
chromosome is now present on the C3H background in CR line C3H.OL. 
H-Y  * was derived from chromosomes H-2  "* and H-2  ~ (A.SW)  (3). 1' 2 The H-2  a  chromo- 
some is present on the A background in a CR line A.TL. 
H-2v originated from a B10.A (H-2") X  T138  (H-2q) hybrid (9). It is now present in non- 
inbred strain AQR. It is also being transferred to the B10 background but the B10.AQR line 
is not yet fully congenic with C57BL/10. 
Origin of Mouse Strains Employed.--Breeding pairs of strains B 10.A (H-2a), C57BL/lOSn 
(=B10)  (H-2~), B10.D2  (H-zd),  B10.A(2R)  (H-2~),  B10.A(SR)  (H-g~a), and  B10.BR 
(H-2 k) were obtained from the Jackson Laboratory, Bar Harbor, Maine. Breeding pairs of 
strains B10.A(4R)  (H-2  h°) and B10.AKM (H-2  ~) were kindly supplied by Dr. J. H. Stimp- 
fling,  McLaughlin  Research  Institute,  Columbus  Hospital,  Great  Falls,  Mont.  All  these 
strains have been maintained by sib-sib matings in the mouse colony of the senior author. 
Strains C3H.D  (H-2d),  C3H.OH  (H-2°h),  C3H.OL  (H-2°t),  A.TL  (H-2aO, HTG  (tt-2g), 
HTI (H-21°), and C3H/He (H-2 k) are maintained by the junior author. 
Skin Grafting.--The  method of Billingham and Medawar (2),  modified as described pre- 
viously (7), was used. The grafts were taken from the ears of the donors. The recipients were 
inspected daily for the first 2 wk after the removal of the bandage (8 days postoperatively) 
and once a  week thereafter. At 60  days postgrafting the experiment was terminated, since 
there was no reason to expect rejection due to H-2 incompatibilities after this period of time. 
RESULTS 
As mentioned above, there are presently two possible interpretations of the 
genetic organization of the H-2 system. We shall call them hypothesis I  and 
hypothesis II. According to hypothesis I,  the H-2  system is composed of a 
minimum of eight regions, six of which control transplantation antigens (regions 
K, A, E,  V, C, and D), and there is no cross-reactivity between the different 
regions. The origin of the 14 well-defined H-2 crossovers, according to hypothe- 
sis I, is shown in Fig. 1. Hypothesis II, on the other hand, requires only four 
H-2 regions, of which only two control transplantation antigens (regions H-2K 
and H-2D). However, hypothesis II requires that the products of the two his- 
tocompatibility regions cross-react extensively. The origin of the same fourteen 
H-2  crossovers,  as interpreted by hypothesis II, is shown in Fig. 2. The two 
hypotheses lead to different predictions of the fate of skin grafts in certain 
donor-recipient combinations. An example of the different predictions is shown 
in Fig. 3. Crossovers H-2 ha and H-2 ~ have both been derived from chromosomes 
H-2 ~ and H-2 b. According to hypothesis I, crossover H-Y ~  received from the 
H-2 b chromosome the H-2D region but not regions K, A, E,  V, and C. Cross- 
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E,  V,  C,  and D. Therefore,  the H-2h~/H-2  ~a heterozygote should  not  accept 
H-2  b skin grafts. (It should react against the products of the regions E,  V, and 
C which it does not share with H-2b.) According to hypothesis II, on the other 
hand, crossovers H-2  ha and H-2 i~ received from It-2  b the H-2D and H-2K re- 
gions, respectively, and since (under this hypothesis) there are no other regions 
controlling transplantation antigens in the H-2 system, the H-2ha/H-2 i" heter- 
zygote should  accept H-2  b grafts, providing that there is no reaction  against 
K  Ir-1  Ss- S~p  D 
a ~--_-_-~--I--~----~ 
~, ~-_-_-_-_~  ....  ~--I--~ 
,0 ~  ....  ~  ....  ~--I--~ 
o~ ~  ....  ~  ....  ~-  -I--_~ 
o, ~-_-_--2~-_-I--~-_---~ 
,° ~-_~-_-I  1----~-2--_~ 
, NN 
; Fro.  2.  Origin of fourteen H-2 crossovers  according to hypothesis II (see text). Symbolism 
is2the~same  as in Fig.  1. 
non-H-2 antigens. The 14 well-defined crossovers can be arranged into 82 dif- 
ferent heterozygous combinations, some of which can be tested in a similar way 
(see Fig. 4, in which only combinations involving eight "basic" H-2 crossovers 
are shown; omitted are those which differ from the basic crossovers only at the 
Ss-Slp locus). The combinations which  cannot be tested in  this way are the 
following:  (a)  combinations for which  the  required  donor is not known.  For 
example, heterozygote  H-2~/H-2  °~  could  have  been  tested  against  a  donor 
whose H-2 chromosome had its K-end derived from H-2  b and its D-end derived 
from H-2  ~. However, such a  chromosome is not  presently known.  (b) Combi- 930  TWO-GENE  MODEL  FOR  THE  H-2  HISTOCOMPATIBILITY  SYSTEM 
nations in which the donor and the recipient are not available on the same inbred 
background. For example, the H-2g/H-2 v heterozygote cannot be tested against 
an H-2 d graft  because  neither  H-2o nor H-2Y  is  on the  same  background  as 
H-2 d.  (c)  Combinations  in  which  the  trans-configurations  of  the  H-2K  and 
H-2D regions in the H-2 heterozygote are identical with  one or the  other of the 
two cis-configurations  of the parental H-2 chromosomes. For example, in heter- 
ozygote H-2"/H-2 h~ one trans-configuration,  H-2(KkDb), is identical with H-2 h, 
and the other, H-2(KkDd), is identical with H-2 ~. 
When these  three  types of combinations are excluded,  41  combinations  re- 
main which can be tested. They are listed in Table I  together with the predic- 
H'2b  m 
]~  ~.~hal  I 
H-2 b  segments  controlling transplantation antigens 
l--]  nen-H-2  b segments controllingtransplantation antigens 
I  m----7  chromosomal  segments  which do not control 
L.___~  transplantation  antigens 
FIG. 3.  An example of the test system in which hypotheses  I  and II lead to different 
prediction about the outcome of the transplantation  (see text). Arrows indicate the direction 
of grafting. 
tions  about  the  graft  survival  on  the  basis  of  hypotheses  I  and  II.  The 
predictions about the fate of the graft are based on the following assumptions: 
(a) Ss, Slp, and Ir-1 differences do not induce cellular immunity. This assump- 
tion is relevant to both hypotheses I  and II. The noninvolvement of Ss-Slp in 
histocompatibility  is  well  documented.  For  example,  it  is  known  that  skin 
grafts  exchanged between  strains  C3H.OH  and  C3H.OL,  which  differ at  the 
Ss-Slp  locus  only,  survive  permanently  (D.  C.  Shreffler,  unpublished  data). 
There is no direct evidence as yet that the same assumption holds also for the 
It-1  differences,  but  indirectly  the  assumption  is  supported  by the  fact that 
there is no known relationship  between It-1  and  any of the H-2 antigens  (6). 
(b)  Products  of "silent"  regions  can induce cellular immunity.  By  a  silent 
region we mean instances when a segment of an H-2 chromosome does not pro- JAN  KLEIN  AND  DONALD  C.  SHREFFLER  931 
duce any" serologically detectable antigen. For example, according to hypothesis 
I,  the  C-region of the  H-2 d  chromosome controls  antigen  H-2.3.  The  corre- 
sponding region in the H-2 b chromosome is silent, i.e., no antigen is known to be 
determined  by this  region.  We  assume,  nevertheless  that  the  tt-2 ~ recipient 
should react against a H-2C product of the H-2  b chromosome. This assumption 
is supported by the analogy with non-H-2 loci, most of which have to be con- 
sidered as serologically silent.  It is relevant to hypothesis I  only. 
(c)  Products  of  serologically  identical  regions  of  different  origin  do  not 
produce immunity. For example, the E-region in H-2 b and the E-region in H-2 k 
FIG. 4.  Some  of the heterozygous combinations of the well-defined H-2 crossovers and 
donors which can be theoretically used for testing hypotheses  I and II. Each square repre- 
sents one heterozygous recipient;  each rectangle, one homozygous graft donor. Dotted-line 
rectangles  =  given combination of K and D regions is not known; broken-line rectangles  = 
given H-2 chromosome is not available on a background needed for the test. Arrows indicate 
the direction of grafting. 
both control antigen H-2.5  and there is no other known serological difference 
between the two regions. Although the two E-regions in these two chromosomes 
are  almost  certainly  unrelated  and  therefore  probably  nonidentical,  we  still 
assume, for the sake of simplicity, that the products of these regions will be the 
same. This assumption does not necessarily have to hold. However, if it is in- 
valid,  several  additional  combinations in Table I  would be expected to reject 
grafts under the hypothesis I while the assumption has no bearing on hypothesis 
II. 
(d) Under hypothesis I, the position of crossing-over in some cases is uncer- 
tain. In such cases, we take into consideration only one possibility. For example, 
according to hypothesis I, crossing-over which produced the tt-2 a~ chromosome 932  TWO-GENE  MOD]~L  :FOR  THE  H-2  ItlSTOCOMPATIBILITY  SYSTEM 
TABLE I 
Expected and Observed Outcome of Skin Grafting in Strain Combinations  Testing 
Hypotheses  I  and II  (See Text) 
Donor-recipient combination 
Strain  H-2 type 
Hypothesis I  Hypo-  Observed outcome 
thesm II 
Expected  Differential region  Expected Rejected  Con- 
outcome  outcome  grafts  cluslons 
BI0.D2  --*  (B10.A X  HTG)*  d  -* a/g  A:~  None  A,~  0/7§, Ii  A  (?) 
2R  ~  (BI0.A X  HTG)  ha ~  a/g  A  None  A  0/13§  A  (?) 
4R  ~  (Bt0.A  X  ttTG)  ho  ~  a/g  A (?)  Ss-Slp, E  (?)  A  0/13§  A  (?) 
B10.BR ~  (BI0.A X  C3H.OH)  k  ~  a/oh  A  Ss-Slt)  A  0/10  A 
BI0.D2  ~  (BI0.A X  C3H.OH)  d  ~  a/oh  R¶  A, E  A  0/15  A 
B10.BR ~  (B10.A X  C3H.OL)  k  ~  a/ol  A (?)  C  (?)  A  0/5  A 
B10.D2  --~  (B10.A X  C3H.OH)  d  ~  a/oh  R  A, E  A  0/4  A 
B10.D2  ~  (HTG  X  5R)  d  ~  g/ia  A  None  A  2/15§  A  (?) 
B10  -~  (HTG  X  5R)  b  ~  g/ia  A  Ss-SI9  A  0/7  A  (?) 
2R  ~  (HTG  X  B10.AKM)  ha  --~  g/m  A  (?)  C  (?)  A  2/14§  A  (?) 
4R  --*  (HTG  X  B10.AKM)  ho  ~  g/m  A  (?)  C  (?) E  (?)  A  I/8§  A  (?) 
B10.A  ~  (2R  X  5R)  a  --*  ha/ia  A  None  A  0/8  A 
B10.A  --~  (4R  X  5R)  a  -~  ho/ia  A  None  A  0/6  A 
B10.A  --  (2R  X  HTI)  a  ~  ha/io  A  None  A  ND**  -- 
B10.A  ~  (4R  X  HTI)  a  ~  ho/io  R  V,  E, Ss-Slp  A  ND  -- 
B10  ~  (2R  X  5R)  b  ~  ha/ia  R  V, E,  C, Ss-Slp  A  0/8  A 
B10  -~  (4R  X  5R)  b  ~  ho/ia  R  C  A  0/6  A 
B10  ~  (2R  X  HTI)  b  ~  ha/io  R  C  A  ND  -- 
B10  ~  (4R  X  HTI)  b  ~  ho/io  R  C  A  ND  -- 
B10.BR ~  (2R  X  C3H.OH)  k  ~  ha/oh  A  Ss-Slp  A  0/6  A 
B10.BR -*  (2R  X  C3H.OL)  k  ~  ha/ol  A  None  A  0/8  A 
B10.BR ~  (4R  X  C3H.OH)  k  ~  ho/oh  A  Ss-slp  A  0/5  A 
B10.BR ~  (4R  X  C3H.OL)  k  ~  ho/ol  A  None  A  0/4  A 
BI0.A  ~  (2R  X  A.TL)  a  ~  ha/tl  A  None  A  0/10  A 
B10.A  ~  (4R  X  A.TL)  a  ~  ho/tl  A  None  A  0/12  A 
BI0.A  ~  (2R  X  AQR)  a  ~  ha/y  A  None  A  0/7  A 
Bt0.A  -*  (4R  X  AQR)  a  ~  ho/y  A  None  A  0/5  A 
Bt0.A  ~  (SR  X  B10.AKM)  a  ~  ia/m  A  None  A  0/11  A 
B10.A  ~  (B10.AKM  X  HTI)  a  --~  m/io  A  Ss-Slp  A  ND  -- 
B10.D2  ~  (5R  X  C3tt.OH)  d  .~  ia/oh  R  A, E  A  0/9  A 
C3H.D  ~  (HTI  X  C3H.OH)  d  ~  io/oh  R  A, E, Y  A  ND  -- 
B10.D2  ~  (SR  X  C3H.OL)  d  ~  ia/ol  R  A, E  A  0/5  A 
C3tt.D  ~  (HTI  X  C3H.OL)  d  ~  io/ol  R  A, E, V, Ss-Slp  A  ND  -- 
BI0.BR ~  (B10.AKM  X  C3H.OH)  k  ~  m/oh  A  None  A  0/7  A 
BI0.BR ~  (B10.AKM  X  C3H.OL)  k  ~  m/ol  A  None  A  0/5  A 
B10.A  ~  (B10.AKM  X  A.TL)  a  ~  m/tl  A  Ss-Slp  A  0/20  A 
BI0.A  ~  (B10.AKM  X  AOR)  a  ~  m/y  A  None  A  0/15§  A  (?) 
C3H.D  --*  (C3H.OH  X  A.TL)  d  ~  oh/tl  R  A, E  A  0/15  A 
C3H.D  ~  (C3H.OL  X  A.TL)  d  ~  ol/tl  R  A, E, Ss-Slp  A  0/5  A 
C3H.D  ~  (C3tt.OH  X  AQR)  d  ~  oh/y  R  A, E  A  0/15§  A  (?) 
C3H.D  ~  (C3H.OL  X  AQR)  d  --*  o]/y  R  A, E  A  0/6  A 
2R =  BI0.A(2R); 4R  =  BlO.A(4R); 5R =  B10.A(5R); B10 =  C57BL/10Sn. 
* F, hybrids. Arrow indicates direction of transplantation. 
** A  =  accepted. 
§ Some grafts developed signs of chronic rejection  (see text). 
11  =  Rejected grafts/total number of grafts performed. 
¶  R  =  Rejected 
** ND  =  not done. 
could have occurred between regions D  and C, C and  V, or V and E. We take 
into account the last possibility only. 
Of the 41 combinations which can be tested, 34 were actually tested and only 
those which involve strain HTI were omitted. In l0 of these 34 combinations, JAN  KLEIN  AND  DONALD  C.  SHREFFLER  933 
hypothesis I  predicts rejection of the donor skin. According to hypothesis II, 
grafts in all 34 combinations should survive permanently (see the left part of 
Table I). The number of skin grafts performed in each combination and the 
number of grafts rejected are shown in the right part of Table I. In all 10 com- 
binations, in which, according to hypothesis I  the grafts should have been re- 
jected,  all the grafts survived permanently. In some of the combinations  in 
which according to both hypotheses the grafts should have been accepted, weak 
histoincompatibilities were detected. These were the following: 
B10.D2 --~ (B10.A)<  HTG)FI: Five grafts were permanently accepted, two 
grafts showed signs of chronic rejection starting at day 45 and 50, respectively. 
2R ~  (B10.A X  HTG)FI: Ten grafts were healthy at day 60, one graft began 
to reject at day 27 but later recovered, and two grafts developed signs of chronic 
rejection between days 37 and 45, respectively. 
4R --~ (B10.A X  HTG)FI: Eleven grafts survived permanently without any 
signs of rejection and two grafts lost their hair crop before the termination of 
the experiment. 
B10 --~ (HTG X  5R)FI: Six grafts remained healthy throughout the whole 
observation period and one graft began slow rejection at day 50. 
B10.A ~  (B10.AKM X AQR)FI: Out of 15 grafts, 10 remained viable for the 
whole observation period and five began a prolonged rejection between days 40 
and 50. 
C3H.D ~  (C3H.OH  X  AQR)FI: One out of 15 grafts began prolonged re- 
jection at day 30. 
In none of the combinations mentioned thus far, was any graft completely 
rejected. The signs of rejection were limited to partial or complete loss of the 
hair crop, appearance of small scars, or swelling of the graft. In the following 
combinations, some grafts were completely destroyed: 
B10.D2 --~ (HTG X  5R)FI: Two out of 15 grafts were rejected, one at day 45 
and the other at day 57. Two grafts showed prolonged rejection starting with 
days 45 and 50, respectively. The rest of the grafts remained healthy. 
2R --+ (HTG X  B10.AKM)FI: Two grafts out of 14 rejected at day 57. The 
rest remained in good shape throughout the whole observation period. 
4R --~ (HTG X  B10.AKM)F~: One graft out of eight was rejected at day 57 
and one showed prolonged rejection beginning at day 45. 
All the combinations in which chronic or acute rejections were observed in- 
volve strains HTG and AQR, both not completely inbred. However, since the 
genetic backgrounds of these two strains should be irrelevant (in the particular 
combinations employed) to the outcome of the grafting, it is difficult to conceive 
how they can be responsible for the observed incompatibilities. 
DISCUSSION 
In this communication, we have shown that certain heterozygous combina- 
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H-2 type, can be used for testing the two possible interpretations of the H-2 
system which we have called here hypothesis I  (system composed of at least six 
histocompatibility regions)  and hypothesis II  (system composed of only two 
histocompatibility regions). The outcome of the transplantation experiment is 
unequivocally in agreement with the predictions based on hypothesis II. In the 
critical ten donor-recipient combinations in which, according to hypothesis I, 
all the grafts should have been rejected, no rejection was observed. In addition 
to this evidence obtained by skin transplantation,  evidence provided by sero- 
logical, genetic, and biochemical  analysis of the H-2  system can be also put 
forward in support of hypothesis II. 
As  earl)' as  1955,  Gorer and his  coworkers  (1,  5)  observed that  some H-2 
antigens could be arranged into series in which antigens of the same series were 
mutually exclusive (i.e., presence of an antigen in a given H-2 type seemed to 
exclude presence of other antigens of the same series). Thus antigens D  (4), D b 
(2) and D k (32), or antigens K (11) and K b (33) never occurred together in any 
of the known H-2 types. Gorer's interpretation of this phenomenon was  that 
antithetical  antigens of the same series were controlled by alleles of the same 
gene.  (This was reflected in the notation used by Gorer, in which the super- 
scripts over the same capital letter designated alMic forms of a given antigen.) 
The idea of mutually exclusive series of H-2 antigens has again been stressed 
recently by Snell and coworkers (23). According to Snell, the private antigens 
of the H-2 system can be arranged into two such series, one determined by the 
K-end and the other by the D-end, relative to the Ss-Slp locus. The two series 
of antigens can be best explained by the assumption that they are controlled by 
two series of alleles,  i.e., alleles at the H-2K locus and alleles at the H-2D locus. 
However, since the public H-2 antigens do not fit easily into this scheme, the 
serology alone does not prove that there are only two H-2 loci. 
At the genetic level, the superiority of hypothesis II over hypothesis I  is  in 
its simplicity. Hypothesis II is virtually free of internal inconsistencies. This 
certainly cannot be claimed about hypothesis I. Several II-2 recombinants fit 
the multiregion map constructed on the basis  of hypothesis I  only with  the 
provision that double or even triple crossing-over occurred inside the H-2 sys- 
tem (see Fig. 1). Such events are rather unlikely in a segment which is only 0.5 
map units long and there is no evidence for increased frequency of double cross- 
ing-over in the chromosome carrying the IXth linkage group  (8). On the basis 
of hypothesis II, all the H-2 crossovers can be explained by single recombina- 
tional event  (see  Fig.  2).  Other inconsistencies associated with hypothesis I 
have been discussed in detail by one of us elsewhere (15). 
The strongest evidence supporting hypothesis II, however, has been provided 
by biochemical analysis of the H-2 products. Solubilization and purification of 
the H-2 alloantigens produces two classes of glycopeptides, one which carries 
all the K-end specificities and another which carries all the D-end specificities 
(i.e., specificities which have been tested for) (11). This result is obtained regard- JAN  KLEIN  AND  DONALD  C.  SItREleFLER  935 
less of the strain (H-2 type) involved and solubilization technique applied. It is 
exactly what one would expect if the H-2 alloantigens were controlled by only 
two loci (providing that the H-2 sites reside in proteins and not in carbohy- 
drates). Moreover, the molecular size of each of the two classes of the H-2 gly- 
coproteins (which is not more than 60,000 daltons, thus indicating that not more 
than 400 amino acid residues  are  present in  each molecule) is approximately 
what one might  expect from a  product  of  an  average size  cistron  (approxi- 
mately 1000 nucleotide pairs). It can be argued, of course, that the H-2 products 
are "miniproteins" controlled by less than average size cistrons but then it still 
remains to be explained why such miniproteins resist separation from one an- 
other by the different isolation procedures which have been employed. Another 
possibility, is that the H-2K and H-2D regions are actually series of duplicated 
genes which control identical or very similar proteins. According to this inter- 
pretation, the purified H-2 preparations would consist of a population of mole- 
cules which would be products of several different cistrons. They would behave 
like  a  single homogeneous protein because of the similarity between the  cor- 
responding cistrons.  However, such interpretation assumes  a  high  degree  of 
genetic conservatism in a system which is one of the most polymorphic systems 
known. 
Thus the immunological (transplantation and serological), genetic, and bio- 
chemical findings can all be best explained by the assumption that the H-2 sys- 
tem consists of two histocompatibility loci separated  by a  chromosomal seg- 
ment occupied by unrelated genes. We have suggested (10) that the two loci be 
called H-2D and H-2K, respectively, with superscripts indicating their chromo- 
somal  origin.  Thus,  for example,  chromosome H-2  az  can  also  be  written  as 
H-2KkH-2D  d,  chromosome H-2g  as H-2KdH-2D  b, etc.  (see Fig. 4).  The sym- 
bolism  can  be simplified to H-2~l(KkDd),  H-2g(KaDb),  etc.  If necessary,  the 
Ss-Slp  and Ir-1  loci can  also be included in  the compound symbols, such  as 
H-2  a*  (Kklr-lhSslSlp°D ~) or H-2  g  (Kdlr-liSshSlp°Db), etc. 
In  a  recent  article,  D~mant  et  al.  (4)  also tested the  genetic  relationship 
between  different H-2  crossovers by  transplantation  methods.  Although  the 
design of their experiment and most of their donor-recipient combinations were 
different from ours, these authors reached the conclusion that  "the  antigenic 
specificities mapping into the central regions of the H-2 locus are secondary to 
those  mapping  into  the  D-region and into the K-region" (4). However, their 
data also fit the hypothesis that  there are no "central" histocompatibility re- 
gions in the H-2 system. 
SUMMARY 
The genetic structure of the H-2 system has been traditionally interpreted as 
consisting of multiple regions controlling histocompatibility antigens. Recently 
however, many difficulties have been encountered in attempts to construct a 
single, consistent linear H-2 map on this basis. We have shown that the genetic, 936  TWO-GENE  MODEL  FOR  THE  H-2  HISTOCOMPATIBILITY SYSTEM 
serological,  and  biochemical  findings  on the  H-2  system can  be  more  readily 
explained  by  the  assumption  that  there  are  only  two  histocompatibility  re- 
gions (loci)  in  the  H-2  system,  H-2D  and H-2K,  which  are separated  by  loci 
.controlling  serum  proteins  (Ss-Slp),  immune  response  (It-l),  and  perhaps 
others. Evidence supporting such an interpretation  of the H-2 system was ob- 
tained  bv a  transplantation  analysis of the  14 well-defined H-2 crossovers.  F1 
hybrids between  different H-2  crossovers were  produced and  challenged  with 
skin grafts from third party strains.  The donor-recipient relationships  in these 
combinations were such that in at least l0 cases the skin grafts should have been 
rejected  if  the  multiple-region  H-2  map  is  correct but should survive perma- 
nently if the two-region model is correct.  In all instances,  the skin grafts  sur- 
vived permanently, providing further evidence for the  two-region  map  of the 
H-2 complex. 
The authors wish to thank Mr. Jong M. Park and Mrs. Patricia  D. Murphy for their ex- 
cellent technical assistance. 
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